Induction of Epigenetic Alterations by Chronic Inflammation and Its Significance on Carcinogenesis

Advances in Genetics

Volumn 71, Issue C, 2010, Pages 41-56

  Niwa, Tohru ^a   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

DNA methylation; Epigenetics; Histone modification; Inflammation

Indexed keywords

CYTOKINE; RNA POLYMERASE II;

ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; INFLAMMATION; METABOLISM; NEOPLASM;

CELL PROLIFERATION; CHRONIC DISEASE; CYTOKINES; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; NEOPLASMS; RNA POLYMERASE II;

EID: 77957351501     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-380864-6.00002-X     Document Type: Book

References (63)

1. Bianchi C., Bianchi T. Malignant mesothelioma: Global incidence and relationship with asbestos. Ind. Health 2007, 45:379-387.
2. Cappello M., Keshav S., Prince C., Jewell D.P., Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992, 33:1214-1219.
3. Castellone M.D., Teramoto H., Williams B.O., Druey K.M., Gutkind J.S. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310:1504-1510.
4. Chan A.O., Chu K.M., Huang C., Lam K.F., Leung S.Y., Sun Y.W., Ko S., Xia H.H., Cho C.H., Hui W.M., et al. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 2007, 56:595-597.
5. Choi P.M., Zelig M.P. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: Implications for carcinogenesis and prevention. Gut 1994, 35:950-954.
6. Costello J.F., Fruhwald M.C., Smiraglia D.J., Rush L.J., Robertson G.P., Gao X., Wright F.A., Feramisco J.D., Peltomaki P., Lang J.C., et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 2000, 24:132-138.
7. Cotran R.S., Kumar V., Robbins S.L. Robbins pathologic basis of disease 1989, W.B. Saunders company, Philadelphia.
8. De Smet C., Loriot A., Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells. Mol. Cell. Biol. 2004, 24:4781-4790.
9. Deng Y.B., Nagae G., Midorikawa Y., Yagi K., Tsutsumi S., Yamamoto S., Hasegawa K., Kokudo N., Aburatani H., Kaneda A. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. Cancer Sci. 2010, (in press).
10. Eads C.A., Lord R.V., Kurumboor S.K., Wickramasinghe K., Skinner M.L., Long T.I., Peters J.H., DeMeester T.R., Danenberg K.D., Danenberg P.V., et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 2000, 60:5021-5026.
11. Ekbom A., Helmick C., Zack M., Adami H.O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 336:357-359.
12. Ekbom A., Helmick C., Zack M., Adami H.O. Ulcerative colitis and colorectal cancer: A population-based study. N. Engl. J. Med. 1990, 323:1228-1233.
13. Ekstrom A.M., Held M., Hansson L.E., Engstrand L., Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001, 121:784-791.
14. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
15. Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 2007, 121:2381-2386.
16. Feinberg A.P., Ohlsson R., Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 2006, 7:21-33.
17. Gal-Yam E.N., Egger G., Iniguez L., Holster H., Einarsson S., Zhang X., Lin J.C., Liang G., Jones P.A., Tanay A. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl. Acad. Sci. USA 2008, 105:12979-12984.
18. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
19. Gloria L., Cravo M., Pinto A., de Sousa L.S., Chaves P., Leitao C.N., Quina M., Mira F.C., Soares J. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 1996, 78:2300-2306.
20. Gomaa A.I., Khan S.A., Toledano M.B., Waked I., Taylor-Robinson S.D. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J. Gastroenterol. 2008, 14:4300-4308.
21. Hahn M.A., Hahn T., Lee D.H., Esworthy R.S., Kim B.W., Riggs A.D., Chu F.F., Pfeifer G.P. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 2008, 68:10280-10289.
22. Heintz N.H., Janssen Y.M., Mossman B.T. Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. USA 1993, 90:3299-3303.
23. Holm T.M., Jackson-Grusby L., Brambrink T., Yamada Y., Rideout W.M., Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 2005, 8:275-285.
24. Hsieh C.J., Klump B., Holzmann K., Borchard F., Gregor M., Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998, 58:3942-3945.
25. Hussain S.P., Harris C.C. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer 2007, 121:2373-2380.
26. Issa J.P., Ahuja N., Toyota M., Bronner M.P., Brentnall T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001, 61:3573-3577.
27. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 1994, 7:536-540.
28. Kaise M., Yamasaki T., Yonezawa J., Miwa J., Ohta Y., Tajiri H. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter 2008, 13:35-41.
29. Kim S.F., Huri D.A., Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005, 310:1966-1970.
30. Klump B., Hsieh C.J., Holzmann K., Gregor M., Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology 1998, 115:1381-1386.
31. Lehmann U., Wingen L.U., Brakensiek K., Wedemeyer H., Becker T., Heim A., Metzig K., Hasemeier B., Kreipe H., Flemming P. Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis. Hum. Mol. Genet. 2007, 16:1335-1342.
32. Llorente L., Richaud-Patin Y., Alcocer-Castillejos N., Ruiz-Soto R., Mercado M.A., Orozco H., Gamboa-Dominguez A., Alcocer-Varela J. Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J. Hepatol. 1996, 24:555-563.
33. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 2006, 12:989-995.
34. McLaughlan J.M., Seth R., Vautier G., Robins R.A., Scott B.B., Hawkey C.J., Jenkins D. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J. Pathol. 1997, 181:87-92.
35. Nakajima T., Maekita T., Oda I., Gotoda T., Yamamoto S., Umemura S., Ichinose M., Sugimura T., Ushijima T., Saito D. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2317-2321.
36. Nakajima T., Oda I., Gotoda T., Hamanaka H., Eguchi T., Yokoi C., Saito D. Metachronous gastric cancers after endoscopic resection: How effective is annual endoscopic surveillance?. Gastric Cancer 2006, 9:93-98.
37. Nakajima T., Yamashita S., Maekita T., Niwa T., Nakazawa K., Ushijima T. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int. J. Cancer 2009, 124:905-910.
38. Narimatsu T., Tamori A., Koh N., Kubo S., Hirohashi K., Yano Y., Arakawa T., Otani S., Nishiguchi S. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Intervirology 2004, 47:26-31.
39. Negishi M., Saraya A., Miyagi S., Nagao K., Inagaki Y., Nishikawa M., Tajima S., Koseki H., Tsuda H., Takasaki Y., et al. Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing. Biochem. Biophys. Res. Commun. 2007, 353:992-998.
40. Nishida N., Nagasaka T., Nishimura T., Ikai I., Boland C.R., Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 2008, 47:908-918.
41. Niwa T., Tsukamoto T., Toyoda T., Mori A., Tanaka H., Maekita T., Ichinose M., Tatematsu M., Ushijima T. Inflammatory Processes Triggered by Helicobacter pylori Infection Cause Aberrant DNA Methylation in Gastric Epithelial Cells. Cancer Res. 2010, 70:1430-1440.
42. Ohm J.E., McGarvey K.M., Yu X., Cheng L., Schuebel K.E., Cope L., Mohammad H.P., Chen W., Daniel V.C., Yu W., et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 2007, 39:237-242.
43. Oka D., Yamashita S., Tomioka T., Nakanishi Y., Kato H., Kaminishi M., Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: A target for risk diagnosis and prevention of esophageal cancers. Cancer 2009, 115:3412-3426.
44. Peng D.F., Kanai Y., Sawada M., Ushijima S., Hiraoka N., Kosuge T., Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci. 2005, 96:403-408.
45. Rollins R.A., Haghighi F., Edwards J.R., Das R., Zhang M.Q., Ju J., Bestor T.H. Large-scale structure of genomic methylation patterns. Genome Res. 2006, 16:157-163.
46. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007, 447:330-333.
47. Sato F., Harpaz N., Shibata D., Xu Y., Yin J., Mori Y., Zou T.T., Wang S., Desai K., Leytin A., et al. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res. 2002, 62:1148-1151.
48. Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E., et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 2007, 39:232-236.
49. Schulmann K., Sterian A., Berki A., Yin J., Sato F., Xu Y., Olaru A., Wang S., Mori Y., Deacu E., et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 2005, 24:4138-4148.
50. Shin H.R., Oh J.K., Masuyer E., Curado M.P., Bouvard V., Fang Y.Y., Wiangnon S., Sripa B., Hong S.T. Epidemiology of cholangiocarcinoma: An update focusing on risk factors. Cancer Sci. 2010, 101:579-585.
51. Solaymani-Dodaran M., Logan R.F., West J., Card T., Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004, 53:1070-1074.
52. Song J.Z., Stirzaker C., Harrison J., Melki J.R., Clark S.J. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 2002, 21:1048-1061.
53. Sun L., Hui A.M., Kanai Y., Sakamoto M., Hirohashi S. Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn. J. Cancer Res. 1997, 88:1165-1170.
54. Takeshima H., Ushijima T. Methylation destiny: Moira takes account of histones and RNA polymerase II. Epigenetics 2010, 5:89-95.
55. Takeshima H., Yamashita S., Shimazu T., Niwa T., Ushijima T. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res. 2009, 19:1974-1982.
56. Tomatis L. Cell proliferation and carcinogenesis: A brief history and current view based on an IARC workshop report. International Agency for Research on Cancer. Environ. Health Perspect. 1993, 101(Suppl 5):149-151.
57. Touati E., Michel V., Thiberge J.M., Wuscher N., Huerre M., Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003, 124:1408-1419.
58. Ushijima T. Epigenetic field for cancerization. J. Biochem. Mol. Biol. 2007, 40:142-150.
59. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.M., et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006, 439:871-874.
60. Wang J.S., Guo M., Montgomery E.A., Thompson R.E., Cosby H., Hicks L., Wang S., Herman J.G., Canto M.I. DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus. Am. J. Gastroenterol. 2009, 104:2153-2160.
61. Widschwendter M., Fiegl H., Egle D., Mueller-Holzner E., Spizzo G., Marth C., Weisenberger D.J., Campan M., Young J., Jacobs I., et al. Epigenetic stem cell signature in cancer. Nat. Genet. 2007, 39:157-158.
62. Yamashita S., Hosoya K., Gyobu K., Takeshima H., Ushijima T. Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis. DNA Res. 2009, 16:275-286.
63. Yoshida, T., Yamashita, S., Takamura-Enya, T., Niwa, T., Ando, T., Enomoto, S., Maekita, T., Nakazawa, K., Tatematsu, M., Ichinose, M., et al. Alu and Satalpha hypomethylation in Helicobacter pylori-infected gastric mucosae. Int J Cancer. (in press).